The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Overview of attention for article published in Blood and Lymphatic Cancer: Targets and Therapy, December 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 10,302 followers.

Of course it’s not #openaccess

The Evolving Role of Brentuximab Vedotin in Classical #Hodgkin Lymphoma | BLCTT @DovePress #lymsm #lymphoma https://t.co/EPankvCRWj

The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma. #lymphoma #lymsm https://t.co/pqs2UWut3A

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.